Growth factor receptors, including the epidermal growth factor receptor (EGFR), are often overexpressed and/or mutated in NSCLC and regulate oncogenic processes including tumor cell proliferation, migration and EMT transition [23], [24], [25], [26], [27]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.